Personalis Inc (PSNL)
5.495
+0.50
(+9.90%)
USD |
NASDAQ |
Nov 05, 14:43
Personalis Total Liabilities (Quarterly): 73.23M for June 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 73.23M |
| March 31, 2024 | 74.58M |
| December 31, 2023 | 95.66M |
| September 30, 2023 | 75.43M |
| June 30, 2023 | 72.95M |
| March 31, 2023 | 78.55M |
| December 31, 2022 | 74.56M |
| September 30, 2022 | 75.46M |
| June 30, 2022 | 93.35M |
| March 31, 2022 | 93.93M |
| December 31, 2021 | 86.23M |
| September 30, 2021 | 81.40M |
| Date | Value |
|---|---|
| June 30, 2021 | 44.59M |
| March 31, 2021 | 47.09M |
| December 31, 2020 | 49.90M |
| September 30, 2020 | 45.27M |
| June 30, 2020 | 52.40M |
| March 31, 2020 | 52.68M |
| December 31, 2019 | 50.60M |
| September 30, 2019 | 48.30M |
| June 30, 2019 | 74.83M |
| March 31, 2019 | 77.95M |
| December 31, 2018 | 148.06M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
44.59M
Minimum
Jun 2021
95.66M
Maximum
Dec 2023
69.36M
Average
74.56M
Median
Dec 2022
Total Liabilities (Quarterly) Benchmarks
| Repligen Corp | 875.56M |
| Myriad Genetics Inc | 344.60M |
| Axogen Inc | 93.24M |
| CareDx Inc | 202.11M |
| Perspective Therapeutics Inc | 44.92M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 185.50M |
| Shareholders Equity (Quarterly) | 112.27M |
| Debt to Equity Ratio | 0.0203 |
| Current Ratio | 3.314 |
| Net Debt Paydown Yield | 0.12% |